Mid and West Essex End of Life and Hospice Services

Description

This is a Contract Award Notice made by the Contracting Authorities; NHS Mid Essex Clinical Commissioning Group, NHS West Essex Clinical Commissioning Group, (hereinafter referred to as “the Authority”) in compliance with their local standing financial instructions (SFIs), for delivery of the following Services; an Inpatient Unit (IPU), a Hospice at Home service, a Bereavement service and a Rapidly Deteriorating Patients – bespoke care service, covering the population of Mid Essex. Additionally IPU, Hospice at Home and Bereavement Services are also delivered in West Essex. This Contract Award Notice follows the Voluntary ex ante transparency notice (2022/S 000-007491) published: 18 March 2022. All services will be contracted for a period of 24 months, from 1st April 2022 – 31st March 2024. The aggregate contract value is forecasted at £8,230,000 (including VAT) over the two-year term, equating to £6,858,333 (excluding VAT). Lot 1: This is a Contract Award Notice made by the Contracting Authorities; NHS Mid Essex Clinical Commissioning Group, NHS West Essex Clinical Commissioning Group, (hereinafter referred to as “the Authority”) in compliance with their local standing financial instructions (SFIs). The contract award is made to Farleigh Hospice for delivery of the following Services; an Inpatient Unit (IPU), a Hospice at Home service, a Bereavement service and a Rapidly Deteriorating Patients – bespoke care service, covering the population of Mid Essex. Additionally IPU, Hospice at Home and Bereavement Services are also delivered in West Essex. This Contract Award Notice follows the Voluntary ex ante transparency notice (2022/S 000-007491) published: 18 March 2022. All services will be contracted for a period of 24 months, from 1st April 2022 – 31st March 2024. The aggregate contract value is forecasted at £8,230,000 (including VAT) over the two-year term, equating to £6,858,333 (excluding VAT). The Contracting Authority is yet to agree appropriate inflation and uplift for this contract for the period of 2022/23 and 2023/24. These will be dealt with as Contract Variations in accordance with the NHS Standard Contract Terms and Conditions. The Authority deems any such variations are not substantial or material changes, as they occur due to external causes beyond the Authority's control, including changes in contract value driven by changes in patient volume. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market, once final. Additional information: The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Contracting Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services.